.png)
.png)
.jpg "Michael J. Satlin photo")
Associate Professor
Weill Cornell Medical Center
Disclosure(s): No financial relationships to disclose
Dr. Michael Satlin an infectious diseases physician and Associate Professor of Medicine and Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine. He is the Clinical Director of the Transplantation-Oncology Infectious Diseases Program at Weill Cornell. He completed medical school at the University of Virginia School of Medicine and internal medicine residency and fellowship training at NewYork-Presbyterian Hospital/Weill Cornell. He also obtained a Master’s Degree in Clinical and Translational Investigation at Weill Cornell. His research focuses on the epidemiology, prevention, and treatment of multidrug-resistant Gram-negative infections, with a particular focus on immunocompromised hosts. He has an R01 grant through the National Institute of Allergy and Infectious Diseases (NIAID) to investigate the role of screening for resistant enteric bacteria to personalized infection prevention strategies in neutropenic patients. He is on the Editorial Advisory Boards of Clinical Infectious Diseases, Open Forum Infectious Diseases, and Journal of Clinical Microbiology, and Associate Editor for Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance. He has authored or co-authored over 90 peer-reviewed manuscripts. He is a Member of the Clinical and Laboratory Standards Institute’s (CLSI) Subcommittee on Antimicrobial Susceptibility Testing and Co-Chair of its Breakpoint Working Group. He is also a member of multiple committees for NIAID’s Antibacterial Resistance Leadership Group and the Prinicipal Investigator for an international prospective study on carbapenem-resistant Pseudomonas aeruginosa infections.